CBPM prescriptions rise annually by 83%
The “number of items for private prescribing of unlicensed cannabis-based medicines” increased from 6,137 in September 2021 to 22,431 in September 2023.
That’s according to an NHS Business Services Authority response to a freedom of information request.
Business of Cannabis report that this equates to an compound annual growth rate of 83%.
However, the UK lags far behind comparable jurisdictions, such as Australia, in terms of overall patient numbers.